Circassia Pharmaceuticals Plc (CIR) - Medical Equipment - Deals and Alliances Profile

GlobalData
30 Pages - GLDATA61668
$250.00

Summary

Circassia Pharmaceuticals plc (Circassia) is a specialty biopharmaceutical company that develops treatments for allergy and respiratory diseases such as asthma. The company’s product NIOX VERO, is used to improve asthma management by assisting diagnosis, determining responsiveness to inhaled corticosteroids, tailoring inhaled steroid use, monitoring treatment compliance and reducing exacerbations. It uses its proprietary technology ToleroMune for the treatment of allergy and NIOX for asthma. Circassia’s products find application in the treatment of allergies and autoimmune conditions caused by cat, house dust mite, grass and ragweed. The company caters to allergy and asthma specialists in the US and Germany. It operates through its offices in Sweden and the US. Circassia is headquartered in Oxford, the UK.

Circassia Pharmaceuticals Plc (CIR) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Circassia Pharmaceuticals Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Circassia Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Circassia Pharmaceuticals Plc, Medical Equipment, Deal Details 11
Asset Purchase 11
Aerocrine Acquires FENO Assets From FILT 11
Venture Financing 11
Prosonix Raises Additional US$9 Million In Series B Financing Round 11
Partnerships 13
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 13
Aerocrine Enters Into Licensing Agreement With Medisoft 14
NanoPass Technologies Enters Into Licensing Agreement With Circassia 15
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits 15
Aerocrine Enters Into Distribution Agreement With Stallergenes For Niox Mino 16
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 17
Aerocrine Enters Into Co-Development Agreement With FILT 18
Equity Offering 19
Aerocrine Raises USD60 Million in Rights Offering of Shares 19
Aerocrine Completes Private Placement Of Shares For US$15 Million 20
Aerocrine Completes Rights Offering Of Common Stock For US$36 Million 21
Acquisition 22
Circassia Pharmaceuticals Acquires Aerocrine 22
Circassia Pharma Acquires Prosonix for USD157.6 Million 24
Circassia Pharmaceuticals Plc - Key Competitors 27
Key Employees 28
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Circassia Pharmaceuticals Plc, Medical Equipment, Key Facts, 2015 1
Circassia Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Circassia Pharmaceuticals Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Circassia Pharmaceuticals Plc, Deals By Market, 2011 to YTD 2017 8
Circassia Pharmaceuticals Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Aerocrine Acquires FENO Assets From FILT 11
Prosonix Raises Additional US$9 Million In Series B Financing Round 11
Circassia Pharma Enters into Licensing Agreement with NanoPass Technologies 13
Aerocrine Enters Into Licensing Agreement With Medisoft 14
NanoPass Technologies Enters Into Licensing Agreement With Circassia 15
Aerocrine Enters Into Distribution Agreement With Shanghai Pharma For Niox Mino And Test Kits 15
Aerocrine Enters Into Distribution Agreement With Stallergenes For Niox Mino 16
Centre of Excellence for Prevention of Organ Failure Enters Into Co-Development Agreement With Adiga Life Sciences For Proteomic And Genomic Biomarkers 17
Aerocrine Enters Into Co-Development Agreement With FILT 18
Aerocrine Raises USD60 Million in Rights Offering of Shares 19
Aerocrine Completes Private Placement Of Shares For US$15 Million 20
Aerocrine Completes Rights Offering Of Common Stock For US$36 Million 21
Circassia Pharmaceuticals Acquires Aerocrine 22
Circassia Pharma Acquires Prosonix for USD157.6 Million 24
Circassia Pharmaceuticals Plc, Key Competitors 27
Circassia Pharmaceuticals Plc, Key Employees 28
Circassia Pharmaceuticals Plc, Subsidiaries 29

List of Figures
Circassia Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Circassia Pharmaceuticals Plc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Circassia Pharmaceuticals Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Circassia Pharmaceuticals Plc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838